Maxicuma®

Individual Ingredient

Maxicuma®

Produced by India's IGL using patented water-dispersion technology, standardized to 40% curcumin, significantly enhancing the absorption of free-form curcumin. With a daily dose of only 100–250 mg, it effectively supports joint health and mobility. Human studies have shown that its bioavailability can be up to 172 times higher than that of conventional 95% curcumin extracts.

Benefits

  • Bone & joint

Need sourcing details for this ingredient?

Send us the ingredient name and your requirement. We will help confirm the next practical step.